Neuromedin U, rat (TFA)

OC(C(F)(F)F)=O.O=C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(O)=O)C(NCC(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N2[C@@H](CCC2)C(N[C@@H](CO)C(NCC(NCC(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CC(C)C)C(N[C@@H](CC5=CC=CC=C5)C(N[C@@H](CCCNC(N)=N)C(N6[C@@H](CCC6)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC7=CC=C(C=C7)O)N

[1]Liu JJ, et al. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2. J Pharmacol Exp Ther. 2009 Jul;330 (1) :268-75.